| Literature DB >> 32717968 |
Nicola Hirsch1, Eva Kappe1, Armin Gangl1, Keike Schwartz2, Anne Mayer-Scholl2, Jens Andre Hammerl2, Eckhard Strauch2.
Abstract
Vibrio cholerae non-O1, non-O139 bacteria are natural inhabitants of aquatic ecosystems and have been sporadically associated with human infections. They mostly lack the two major virulence factors of toxigenic V. cholerae serogroups O1 and O139 strains, which are the causative agent of cholera. Non-O1, non-O139 strains are found in water bodies, sediments, and in association with other aquatic organisms. Occurrence of these bacteria in fecal specimens of waterfowl were reported, and migratory birds likely contribute to the long-distance transfer of strains. We investigated four V. cholerae non-O1, non-O139 isolates for phenotypic traits and by whole genome sequencing (WGS). The isolates were recovered from organs of domestic ducks with serious disease symptoms. WGS data revealed only a distant genetic relationship between all isolates. The isolates harbored a number of virulence factors found in most V. cholerae strains. Specific virulence factors of non-O1, non-O139 strains, such as the type III secretion system (TTSS) or cholix toxin, were observed. An interesting observation is that all isolates possess multifunctional autoprocessing repeats-in-toxin toxins (MARTX) closely related to the MARTX of toxigenic El Tor O1 strains. Different primary sequences of the abundant OmpU proteins could indicate a significant role of this virulence factor. Phenotypic characteristics such as hemolysis and antimicrobial resistance (AMR) were studied. Three isolates showed susceptibility to a number of tested antimicrobials, and one strain possessed AMR genes located in an integron. Knowledge of the environmental occurrence of V. cholerae non-O1, non-O139 in Germany is limited. The source of the infection of the ducks is currently unknown. In the context of the 'One Health' concept, it is desirable to study the ecology of V. cholerae non-O1, non-O139, as it cannot be excluded that the isolates possess zoonotic potential and could cause infections in humans.Entities:
Keywords: antimicrobial resistance; diseased birds; phylogenetic analysis; virulence factors
Year: 2020 PMID: 32717968 PMCID: PMC7463538 DOI: 10.3390/microorganisms8081104
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Vibrio cholerae non-O1, non-O139 strains used in this study.
| Strain | Year of Isolation | Source | Origin | Information on Disease |
|---|---|---|---|---|
| 17-VB00405 | 2017 | Duck/liver | Bavaria/Germany | Mild fibrinous-purulent hepatitis |
| 16-VB00145 | 2016 | Duckling/liver | Bavaria/Germany | Premature death/stunted growth/lameness |
| T58 | 2011 | Duck/jejunum | Saxony/Germany | Pneumonia/peritonitis |
| CH415 | 1996 | Duckling/lung | Saxony/Germany | Dyspnea/polyserositis/pneumonia/inability to stand |
Multiplex PCR for species (sodB), cholera toxin gene (ctxA) and serogroups O1 and O139 detection.
| Gene/Target | Primer | Sequence (5′ to 3′) | Amplicon Size (bp) | Ta (°C) | References |
|---|---|---|---|---|---|
|
| VcsodBf | AAGACCTCAACTGGCGGTA | 248 | [ | |
| VcsodBR | GAAGTGTTAGTGATCGCCAGAGT | ||||
|
| ctxA1 | CTCAGACGGGATTTGTTAGGCACG | 301 | [ | |
| ctxA2 | TCTATCTCTGTAGCCCCTATTACG | 59 | |||
| O1F | GTTTCACTGAACAGATGGG | 192 | [ | ||
| O1R | GGTCATCTGTAAGTACAAC | ||||
| O139F | AGCCTCTTTATTACGGGTGG | 449 | [ | ||
| O139R | GTCAAACCCGATCGTAAAGG |
Figure 1Liver, H&E stain, 200× magnification. Hepatitis with mild degeneration and vacuolation of hepatocytes, heterophilic to mixed inflammatory cell infiltration (stars), small deposits of fibrin (thick arrow), and individual cell necrosis (thin arrows).
Species confirmation by Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and average nucleotide identity (ANI).
| Isolate | MALDI-TOF MS | Average Nucleotide Identity ** | |
|---|---|---|---|
| Score * | Interpretation | ||
| CH415 | 2.38 | Highly probable identification to species level | 98.26% |
| T58 | 2.28 | Probable identification to species level | 98.06% |
| 16-VB00145 | 2.33 | Highly probable identification to species level | 98.06% |
| 17-VB00405 | 2.30 | Highly probable identification to species level | 98.25% |
* Quality of species identification according to Bruker instruction against Bruker main spectra (MSP) libraries. ** Pairwise comparison to genome of strain V. cholerae O1 El Tor strain 16961 (accession: NC_002505.1 and NC_002506.1, two-way ANI results): http://enve-omics.ce.gatech.edu/ani/.
Figure 2Single nucleotide polymorphism (SNP)-based phylogenetic relationships of V. cholerae non-O1, non-O139 isolates. Strains from ducks are marked with a circle. Four similar genomes of V. cholerae strains identified by bioinformatics were included in the tree. The SNP tree was conducted using CSI Phylogeny 1.4 under default settings and the exclusion of heterozygous SNPs. Single nucleotide polymorphisms (SNPs) were called by mapping to the V. cholerae O1 El Tor N16961 genome as a reference (accession NC_002505.1, NC_002506.1). The scale bar represents the number of nucleotide substitutions per site and numbers indicate branch length. Accession of V. cholerae (V.chol) genomes: LBGA01000000 (YB02G07), JMBP00000000 (V.chol 254-93), KQ410623 (V.chol 1587), NMSW00000000 (V.chol OYP8A01).
Virulence factors found in duck isolates.
| Virulence Factors/Function. | Related Genes | CH415 | T58 | 16-VB00145 | 17-VB00405 | Reference |
|---|---|---|---|---|---|---|
| CTX prophage/cholera toxin | n.d. | n.d. | n.d. | n.d. | [ | |
| n.d. | n.d. | n.d. | n.d. | [ | ||
| VC1776-VC1783 (SA transport, SA catabolism) VC1784 ( | n.d. | n.d. | VC1776-VC1784 | n.d. | [ | |
| Type three secretion system * core region, 5′ and 3′ flanking region | n.d. | present | n.d. | n.d. | [ | |
| VC0175-VC0185 | n.d. | n.d. | n.d. | n.d. | [ | |
| VC0490-VC0516 | n.d. | VC0504-VC0510, VC0516 | n.d. | VC0490-VC0516 | [ | |
| Repeats-in-toxin (RTX) toxins/cytotoxin | present | present | present | present | [ | |
| Mannose-sensitive hemagglutinin pilus (MSHA pilus)/adhesion |
| present | n.d. | n.d. | n.d. | [ |
| Hemolysin genes/cytotoxins | present | present | present | present | [ | |
| Outer membrane protein/defense |
| present | present | present | present | [ |
| Type VI secretion system (T6SS) core genes, effectors/interaction | present | present | present | present | [ | |
| Quorum sensing/autoinducer | present | present | present | present | [ | |
| Hemagglutination/protease |
| present | present | present | present | [ |
| Cholix toxin*/ADP-ribosylating toxin |
| n.d. | n.d. | n.d. | present | [ |
| Virulence gene expression/transcriptional activator |
| present | present | present | present | [ |
| Heat-stable enterotoxin * |
| n.d. | n.d. | n.d. | n.d. | [ |
* Factors present in non-O1, non-O139 strains. n.d.—not detected. Gene numbers starting with VC are from genome annotation of O1 El Tor reference strain N16961 (16961 (accession: NC_002505.1and NC_002506.1).
Phenotypic and genotypic results of antimicrobial resistance of V. cholerae non-O1, non-O139 strains.
| Isolate | AMP | CHL | CIP | COL | FOX | GEN | NAL * | SMX | TAZCLA | TEMOCI * | TET | TMP | AMR Genes ** |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| 4 | ≤8 | 0.03 | >16 | 8 | 2 | 16 | 512 | ≤0.12 | 4 | ≤2 | >32 | |
|
| 4 | ≤8 | ≤0.015 | >16 | 8 | ≤0.5 | ≤4 | ≤8 | ≤0.12 | 2 | ≤2 | 0.5 |
|
|
| 2 | ≤8 | ≤0.015 | >16 | 4 | 1 | ≤4 | ≤8 | ≤5 | 2 | ≤2 | 0.5 |
|
|
| 2 | ≤8 | ≤0.015 | >16 | 8 | ≤0.5 | ≤4 | ≤8 | ≤0.12 | 2 | ≤2 | 0.5 |
|
Only selected phenotypes are shown (a complete list is given in Table S1). Gray boxes indicate resistance, MIC concentration in [µg/mL]. Interpretation criteria according to CLSIAbbreviations: AMP ampicillin, CHL chloramphenicol, CIP ciprofloxacin, COL colistin, FOX cefoxitin, GEN gentamicin, NAL nalidixic acid, SMX sulfamethoxazole, TAZCLA ceftazidime/clavulanic acid, TEMOCI temocillin, TET tetracycline, TMP trimethoprim. * no criteria specified by CLSI [20]. ** AMR genes derived from genome sequences are aadA1 (coding for aminoglycoside nucleotidyltransferase), catB9 (chloramphenicol acetyltransferase), sul1 (sulfonamide resistant dihydropteroate synthase), and dfr1 (dihydrofolate reductase). The gyrA gene (nalidixic acid resistance) has a mutation: aspartic acid to glycine in amino acid position 87.